Arrowstreet Capital Limited Partnership Takes $205,000 Position in Grail, Inc. (NASDAQ:GRAL)

Arrowstreet Capital Limited Partnership purchased a new position in Grail, Inc. (NASDAQ:GRAL - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 11,501 shares of the company's stock, valued at approximately $205,000.

Other hedge funds also recently bought and sold shares of the company. Crcm LP purchased a new stake in Grail during the 4th quarter valued at $65,061,000. Primecap Management Co. CA purchased a new position in Grail during the fourth quarter valued at approximately $37,118,000. Vanguard Group Inc. bought a new position in shares of Grail in the fourth quarter worth approximately $25,902,000. Bank of New York Mellon Corp purchased a new stake in shares of Grail in the fourth quarter worth $6,262,000. Finally, TCW Group Inc. bought a new stake in shares of Grail during the 4th quarter valued at $5,095,000.

Insider Activity

In other news, CFO Aaron Freidin sold 1,816 shares of Grail stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $31.20, for a total transaction of $56,659.20. Following the completion of the sale, the chief financial officer now owns 335,170 shares of the company's stock, valued at approximately $10,457,304. The trade was a 0.54 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Robert P. Ragusa sold 7,625 shares of the company's stock in a transaction on Friday, March 7th. The stock was sold at an average price of $31.21, for a total value of $237,976.25. Following the sale, the chief executive officer now owns 828,662 shares of the company's stock, valued at approximately $25,862,541.02. This represents a 0.91 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 11,550 shares of company stock valued at $360,436.

Grail Stock Performance

NASDAQ GRAL traded up $0.50 on Friday, reaching $27.00. The company had a trading volume of 642,745 shares, compared to its average volume of 1,221,381. The firm's 50 day moving average price is $32.83 and its 200 day moving average price is $23.57. Grail, Inc. has a 12 month low of $12.33 and a 12 month high of $63.99.

Grail (NASDAQ:GRAL - Get Free Report) last issued its quarterly earnings results on Thursday, February 20th. The company reported ($1.86) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($4.41) by $2.55. The company had revenue of $38.25 million during the quarter, compared to the consensus estimate of $35.33 million. As a group, analysts anticipate that Grail, Inc. will post -15.15 EPS for the current fiscal year.

Analysts Set New Price Targets

Separately, Morgan Stanley upped their target price on shares of Grail from $16.00 to $20.00 and gave the stock an "equal weight" rating in a report on Tuesday, March 18th.

Grail Company Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.